BUFFALO, N.Y. -- Gil I. Wolfe, MD, a leading authority on
neuromuscular disorders at the University of Texas (UT)
Southwestern Medical School, has been named the Irvin and Rosemary
Smith Professor and Chair of the Department of Neurology in the
University at Buffalo's School of Medicine and Biomedical
Wolfe will join UB in December from UT, where he is the Dr. Bob
and Jean Smith Foundation Distinguished Chair in Neuromuscular
Disease Research, and professor of neurology and
"Dr. Wolfe is an outstanding physician-scientist and educator,"
said Michael E. Cain, MD, UB vice president for health sciences and
dean of the School of Medicine and Biomedical Sciences. "His
leadership abilities will enable him to expand the department's
research, educational and clinical programs and best develop and
align with UB 2020's strategic goals a comprehensive clinical
program at Great Lakes Health, Roswell Park Cancer Institute and
Wolfe is the seventh new chair or high-level physician that Cain
has hired in the past three years, an effort that he says is a
critical piece of his strategic vision for the medical school.
A native of New York City, Wolfe received his undergraduate
degree from Princeton University and his medical degree from UT
Southwestern Medical School. He completed an internal medicine
internship and trained as a neurology resident and
neuromuscular/electromyography fellow at the University of
Pennsylvania Medical Center in Philadelphia.
Wolfe joined the faculty of UT Southwestern as an assistant
professor of neurology in 1994. In addition to his current role as
Distinguished Chair of Neuromuscular Disease Research and
professor, he serves as clinical vice chair of the Department of
Neurology and chief of the Neuromuscular Division.
He also is director of the Neuromuscular Medicine Fellowship
Program, co-director of the Muscular Dystrophy Association Clinics
and director of the Peripheral Neuropathy Clinic at UT
Southwestern. He formerly directed the school's neurology residency
and neurophysiology fellowship programs.
Wolfe's primary research interests are idiopathic and
immune-mediated peripheral neuropathies and myasthenia gravis. He
has authored or co-authored more than 80 research papers and 15
chapters on neuromuscular disorders.
His research has been sponsored by the Muscular Dystrophy
Association, Myasthenia Gravis Foundation of America, Food and Drug
Administration and National Institute of Neurological Disorders and
Stroke in the National Institutes of Health.
Wolfe is certified by the American Board of Psychiatry and
Neurology in neurology, neuromuscular medicine and clinical
neurophysiology. He was elected to membership in the American
Neurological Association in 2004 and is a Fellow of the American
Academy of Neurology.
He has lectured nationally and internationally, serves on
editorial boards of leading medical and scientific journals in his
field and holds leadership positions in several professional
Wolfe serves on the medical advisory boards for the Myasthenia
Gravis Foundation of America, the Neuropathy Association and
Charcot-Marie-Tooth Association. He has received UT Southwestern's
Trephined Cranium Award for Excellence in Residency Teaching on
The University at Buffalo is a premier research-intensive
public university, the largest and most comprehensive campus in the
State University of New York. UB's more than 28,000 students pursue
their academic interests through more than 300 undergraduate,
graduate and professional degree programs. Founded in 1846, the
University at Buffalo is a member of the Association of American